Spero Therapeutics to Attend Healthcare Conference
News related to:Spero Therapeutics · 1 min read
CAMBRIDGE, Mass., Oct. 15, 2026 /CourierPR/ -- Spero Therapeutics, a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, has announced that Esther Rajavelu, the company's President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference. The conference is scheduled to take place in New York City on October 20th, 2026.
The company's leadership team will also be available for one-on-one meetings at the conference, which is expected to provide a platform for industry professionals to engage with Spero Therapeutics and its management team.
Spero Therapeutics' lead program, SP001, is a third-generation, Fc-silent anti-CD40L monoclonal antibody being advanced first in IgG4-related disease, with potential for development in additional immunological and inflammatory diseases.
Spero Therapeutics, a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, has announced that Esther Rajavelu, the company's President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference. The conference is scheduled to take place in New York City on October 20th, 2026. Spero's leadership team will also be available for one-on-one meetings at the conference, which is expected to provide a platform for industry professionals to engage with Spero Therapeutics and its management team. Spero Therapeutics' lead program, SP001, is a third-generation, Fc-silent anti-CD40L monoclonal antibody being advanced first in IgG4-related disease, with potential for development in additional immunological and inflammatory diseases. The webcast of the conference may also be accessed through Spero's website on the Events + Presentations page. A replay of the conference will be available for approximately 90 days following the event. To request a meeting or for more details about the conference, please contact your institutional representative at Chardan.